Toshitsugu Sugimoto

Overview

Best Publications

• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  Kenneth B Jonsson;Richard Zahradnik;Tobias Larsson;Kenneth E White

  955
  Citations

• Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

  Ippei Kanazawa;Toru Yamaguchi;Masahiro Yamamoto;Mika Yamauchi

  572
  Citations

• Plasma Lipids and Osteoporosis in Postmenopausal Women

  Toru Yamaguchi;Toshitsugu Sugimoto;Shozo Yano;Mika Yamauchi

  433
  Citations

• Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary

  Hajime Orimo;Toshitaka Nakamura;Takayuki Hosoi;Masayuki Iki

  428
  Citations

• Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications

  Masahiro Yamamoto;Toru Yamaguchi;Mika Yamauchi;Hiroshi Kaji

  393
  Citations

• Diagnostic criteria for primary osteoporosis: year 2012 revision

  Satoshi Soen;Masao Fukunaga;Toshitsugu Sugimoto;Teruki Sone

  365
  Citations

• Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells

  Toru Yamaguchi;Naibedya Chattopadhyay;Olga Kifor;Robert R. Butters

  356
  Citations

• Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons

  Toshiyuki Yoneda;Hiroshi Hagino;Toshitsugu Sugimoto;Hiroaki Ohta

  340
  Citations

• Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

  I. Kanazawa;T. Yamaguchi;M. Yamauchi;M. Yamamoto

  327
  Citations

• Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

  Toshitaka Nakamura;Toshitsugu Sugimoto;Tetsuo Nakano;Hideaki Kishimoto

  313
  Citations

• Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes

  Masahiro Yamamoto;Toru Yamaguchi;Mika Yamauchi;Shozo Yano

  308
  Citations

• Serum Levels of Insulin-like Growth Factor (IGF) I, IGF-Binding Protein (IGFBP)-2, and IGFBP-3 in Osteoporotic Patients with and without Spinal Fractures

  Toshitsugu Sugimoto;Katsuhito Nishiyama;Fumihiko Kuribayashi;Kazuo Chihara

  270
  Citations

• Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.

  Ippei Kanazawa;Toru Yamaguchi;Shozo Yano;Mika Yamauchi

  266
  Citations

• Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS

  Murat Bastepe;Leopold F. Fröhlich;Geoffrey N. Hendy;Olafur S. Indridason

  261
  Citations

• Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

  Itsuro Endo;Seiji Fukumoto;Keiichi Ozono;Noriyuki Namba

  252
  Citations

• Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells

  Ippei Kanazawa;Toru Yamaguchi;Shozo Yano;Mika Yamauchi

  230
  Citations

• Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.

  Toshiyuki Yoneda;Hiroshi Hagino;Toshitsugu Sugimoto

  227
  Citations

• High Extracellular Calcium Inhibits Osteoclast-like Cell Formation by Directly Acting on the Calcium-Sensing Receptor Existing in Osteoclast Precursor Cells

  Masanori Kanatani;Toshitsugu Sugimoto;Michiko Kanzawa;Shozo Yano

  220
  Citations

• Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor β-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2

  Hideaki Sowa;Hiroshi Kaji;Geoffrey N. Hendy;Lucie Canaff

  194
  Citations

• Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells.

  Ken-ichiro Tanaka;Toru Yamaguchi;Ippei Kanazawa;Toshitsugu Sugimoto

  192
  Citations